Modulation of 5-Lipoxygenase in Proteotoxicity and Alzheimer's Disease.
- Published in:
- Journal of Neuroscience, 2013, v. 33, n. 25, p. 10512, doi. 10.1523/JNEUROSCI.5183-12.2013
- By:
- Publication type:
- Article
Works by Dargusch, Richard
Results: 16
1
2
The mitochondrial ATP synthase is a shared drug target for aging and dementia.
- Published in:
- Aging Cell, 2018, v. 17, n. 2, p. 1, doi. 10.1111/acel.12715
- By:
- Publication type:
- Article
3
Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice.
- Published in:
- Aging Cell, 2014, v. 13, n. 2, p. 379, doi. 10.1111/acel.12185
- By:
- Publication type:
- Article
4
Isolation and Characterization of Novel Presenilin Binding Protein.
- Published in:
- Journal of Neurochemistry, 2000, v. 75, n. 1, p. 109, doi. 10.1046/j.1471-4159.2000.0750109.x
- By:
- Publication type:
- Article
5
A novel Alzheimer's disease drug candidate targeting inflammation and fatty acid metabolism.
- Published in:
- Alzheimer's Research & Therapy, 2017, v. 9, p. 1, doi. 10.1186/s13195-017-0277-3
- By:
- Publication type:
- Article
6
Lactacidosis modulates glutathione metabolism and oxidative glutamate toxicity.
- Published in:
- Journal of Neurochemistry, 2010, v. 113, n. 2, p. 502, doi. 10.1111/j.1471-4159.2010.06621.x
- By:
- Publication type:
- Article
7
A broadly neuroprotective derivative of curcumin.
- Published in:
- Journal of Neurochemistry, 2008, v. 105, n. 4, p. 1336, doi. 10.1111/j.1471-4159.2008.05236.x
- By:
- Publication type:
- Article
8
F-spondin.
- Published in:
- Journal of Neurochemistry, 2006, v. 96, n. 2, p. 444, doi. 10.1111/j.1471-4159.2005.03563.x
- By:
- Publication type:
- Article
9
Detecting bioactive amyloidβ peptide species in Alzheimer's disease.
- Published in:
- Journal of Neurochemistry, 2004, v. 91, n. 3, p. 648, doi. 10.1111/j.1471-4159.2004.02751.x
- By:
- Publication type:
- Article
10
A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease.
- Published in:
- PLoS ONE, 2011, v. 6, n. 12, p. 1, doi. 10.1371/journal.pone.0027865
- By:
- Publication type:
- Article
11
Fisetin Lowers Methylglyoxal Dependent Protein Glycation and Limits the Complications of Diabetes.
- Published in:
- PLoS ONE, 2011, v. 6, n. 6, p. 1, doi. 10.1371/journal.pone.0021226
- By:
- Publication type:
- Article
12
Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer's Disease.
- Published in:
- Molecular Neurobiology, 2019, v. 56, n. 11, p. 7719, doi. 10.1007/s12035-019-1637-8
- By:
- Publication type:
- Article
13
Diverse proteins aggregate in mild cognitive impairment and Alzheimer's disease brain.
- Published in:
- Alzheimer's Research & Therapy, 2020, v. 12, n. 1, p. 1, doi. 10.1186/s13195-020-00641-2
- By:
- Publication type:
- Article
14
Fisetin Reduces the Impact of Aging on Behavior and Physiology in the Rapidly Aging SAMP8 Mouse.
- Published in:
- 2018
- By:
- Publication type:
- journal article
15
ERK activation by the polyphenols fisetin and resveratrol provides neuroprotection in multiple models of Huntington's disease.
- Published in:
- Human Molecular Genetics, 2011, v. 20, n. 2, p. 261, doi. 10.1093/hmg/ddq460
- By:
- Publication type:
- Article
16
The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice.
- Published in:
- Alzheimer's Research & Therapy, 2013, v. 5, n. 3, p. 1, doi. 10.1186/alzrt179
- By:
- Publication type:
- Article